TCL_screen_Asset 65.png

 

about test cure live

TEST CURE LIVE is a national hepatitis C awareness campaign that aims to engage and motivate people living with hepatitis C to speak to their doctor about testing and/or cure.

Around 182,000 Australians live with chronic hepatitis C infection, a blood-borne virus which can lead to liver cancer and liver failure if not treated.

New highly-effective cures, known as direct-acting antivirals (DAAs), were first listed on the Pharmaceutical Benefits Scheme in March 2016. In comparison, previous therapies were grueling and relatively ineffective.

Despite initial publicity, many people living with hepatitis C remain unaware of the benefits or availability of the new cures. These Australians are missing out on potentially life-saving therapies which are readily available on prescription from their GP and can cure hepatitis C in as little as eight weeks.

Hepatitis Australia will work in collaboration with its member organisations to implement the TEST CURE LIVE campaign throughout Australia from February 2019 to April 2020. The localised campaigns will be implemented in three cycles with an evaluation and planning element between each cycle, enabling us to continually improve the TEST CURE LIVE campaign.

Cycle 1: February – April 2019. Canberra and Adelaide

Cycle 2: August – October 2019. Tasmania, Western Australia, Queensland, Northern Territory

Cycle 3: February – April 2020. New South Wales, Victoria,

The TEST CURE LIVE campaign is supported by funding from the Australian Government Department of Health.

 

 

 

We welcome your feedback

In our continuous effort to improve the work that we do, we welcome your thoughts, questions and feedback on the TEST CURE LIVE website, resources and campaign.

Name *
Name